Strength
8 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547055709
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
ROPINIROLEApproval Type
Generic (ANDA)
FDA Application
ANDA204413On Market Since
3/22/2022
Pharmacological Classes
Dopamine Agonists
Nonergot Dopamine Agonist
Related Drugs
Same classification
PRAMIPEXOLE 0.125 MG TABLET
Generic
13668009105•Torrent Pharmaceuticals Limited
$0.0425
per EA
PRAMIPEXOLE 0.125 MG TABLET
Generic
13668009190•Torrent Pharmaceuticals Limited
$0.0425
per EA
PRAMIPEXOLE 0.125 MG TABLET
Generic
50228012610•ScieGen Pharmaceuticals Inc.
$0.0425
per EA
PRAMIPEXOLE 0.125 MG TABLET
Generic
57237018090•Rising Pharma Holdings Inc.
$0.0425
per EA
PRAMIPEXOLE 0.125 MG TABLET
Generic
64380074605•Strides Pharma Inc.
$0.0425
per EA
PRAMIPEXOLE 0.125 MG TABLET
Generic
68462033090•Glenmark Pharmaceuticals Inc., USA
$0.0425
per EA
PRAMIPEXOLE 0.125 MG TABLET
Generic
65862060490•Aurobindo Pharma Limited
$0.0427
per EA
ROPINIROLE HCL 0.5 MG TABLET
Generic
43547026910•Solco Healthcare US LLC
$0.0433
per EA
ROPINIROLE HCL 0.5 MG TABLET
Generic
43547026950•Solco Healthcare US LLC
$0.0433
per EA
ROPINIROLE HCL 0.5 MG TABLET
Generic
50268074215•AvPAK
$0.0433
per EA